APO Research
Talk to an analyst

APO RESEARCH · REPORT

Glabridin

Glabridin is a chemical compound that is found in the root extract of licorice (Glycyrrhiza glabra). Glabridin is an isoflavane, a type of isoflavonoid. This product is part of a larger family of plant-derived molecules, the natural phenols. Glabridin is yellowish-brown powder. It is insoluble in water, but soluble in organic solvents such as propylene glycol.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Glabridin is a chemical compound that is found in the root extract of licorice (Glycyrrhiza glabra). Glabridin is an isoflavane, a type of isoflavonoid. This product is part of a larger family of plant-derived molecules, the natural phenols. Glabridin is yellowish-brown powder. It is insoluble in water, but soluble in organic solvents such as propylene glycol.

Selected research

Market Outlook & Growth Opportunities

Global Glabridin Market Outlook and Growth Opportunities 2026

30 December 2025195 pages

Choose your research edition.

Industry ResearchGlabridin Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Glabridin Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Glabridin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Glabridin Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Glabridin Market Analysis and Forecast 2026-2032211 pages · $4,950 USD

Market perspective

Glabridin is a chemical compound that is found in the root extract of licorice (Glycyrrhiza glabra). Glabridin is an isoflavane, a type of isoflavonoid. This product is part of a larger family of plant-derived molecules, the natural phenols. Glabridin is yellowish-brown powder. It is insoluble in water, but soluble in organic solvents such as propylene glycol.

Global Glabridin market can be divided into 20% (HPLC), 40% (HPLC), 60% (HPLC), 90% (HPLC), 98% (HPLC) and Others according to the content of active ingredients. Among them, 40% (HPLC) is the most widely used. Glabridin 40% (HPLC) was estimated to account for a revenue share of 43.54% in 2020. In 2020, Glabridin 40% (HPLC) segment is estimated to be valued at 7778 K USD which is expected to reach at 10718 K USD in 2026, with a CAGR of 5.49% over the forecast period.

Global Glabridin Application segment consists of Cosmetic and Pharmaceutical. Cosmetic was estimated to account for a sales share of 89.17% in 2020. In 2020, the Cosmetic segment is estimated to sale at 2086 Kg which is expected to reach at 2685 Kg in 2026, with a CAGR of 4.29% over the forecast period.This report focuses on the Glabridin in global market, especially in North America, Europe, China, India and Japan. As the largest producer, China produced 949 Kg of Glabridin in 2019, accounting for 37.85% of the global total. The United States is the most important consumer country, with consumption accounting for 24.28% of the global in 2019.

Read the full market overview

This report provides an overview of the global Glabridin market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Glabridin and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Glabridin sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Glabridin market size, projected growth trends, production technologies, key applications, and end-use industries.

Glabridin Segment by Company

Sabinsa

Alchem International

MAFCO

Plamed Green Science Group

Xi'an Zhongying

Spring Autumn Biological

Huaian Brothers Biotechnology

Xi’an Tianye Biotech

Maruzen Pharmaceuticals

SK Bioland

Sunpure Extracts

Glabridin Segment by Type

20% (HPLC)

40% (HPLC)

60% (HPLC)

90% (HPLC)

98% (HPLC)

Other

Glabridin Segment by Application

Cosmetic

Pharmaceutical

Glabridin Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Glabridin status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Glabridin market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Glabridin significant trends, drivers, influence factors in global and regions.

6. To analyze Glabridin competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Glabridin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Glabridin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Glabridin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Glabridin market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Glabridin industry.

Chapter 3: Detailed analysis of Glabridin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Glabridin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Glabridin in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Glabridin Industry Trends Table 2. Glabridin Industry Drivers Table 3. Glabridin Industry Opportunities and Challenges Table 4. Glabridin Industry Restraints Table 5. Global Glabridin Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Glabridin Revenue Share by Company (2021-2026) Table 7. Global Glabridin Sales Volume by Company (Kg) & (2021-2026) Table 8. Global Glabridin Sales Volume Share by Company (2021-2026) Table 9. Global Glabridin Average Price (US$/Kg) of Company (2021-2026) Table 10. Global Glabridin Company Ranking, (2024-2026) & (USD Million) Table 11. Global Glabridin Key Company Manufacturing Base & Headquarters Table 12. Global Glabridin Company, Product Type & Application Table 13. Global Glabridin Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Glabridin by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 20% (HPLC) Table 18. Significant Companies of 40% (HPLC) Table 19. Significant Companies of 60% (HPLC) Table 20. Significant Companies of 90% (HPLC) Table 21. Significant Companies of 98% (HPLC) Table 22. Significant Companies of Other Table 23. Global Glabridin Sales Volume by Type 2021 VS 2025 VS 2032 (Kg) Table 24. Global Glabridin Sales Volume by Type (2021-2026) & (Kg) Table 25. Global Glabridin Sales Volume by Type (2027-2032) & (Kg) Table 26. Global Glabridin Sales Volume Share by Type (2021-2026) Table 27. Global Glabridin Sales Volume Share by Type (2027-2032) Table 28. Global Glabridin Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Glabridin Sales Value by Type (2021-2026) & (US$ Million) Table 30. Global Glabridin Sales Value by Type (2027-2032) & (US$ Million) Table 31. Global Glabridin Sales Value Share by Type (2021-2026) Table 32. Global Glabridin Sales Value Share by Type (2027-2032) Table 33. Significant Companies of Cosmetic Table 34. Significant Companies of Pharmaceutical Table 35. Global Glabridin Sales Volume by Application 2021 VS 2025 VS 2032 (Kg) Table 36. Global Glabridin Sales Volume by Application (2021-2026) & (Kg) Table 37. Global Glabridin Sales Volume by Application (2027-2032) & (Kg) Table 38. Global Glabridin Sales Volume Share by Application (2021-2026) Table 39. Global Glabridin Sales Volume Share by Application (2027-2032) Table 40. Global Glabridin Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Glabridin Sales Value by Application (2021-2026) & (US$ Million) Table 42. Global Glabridin Sales Value by Application (2027-2032) & (US$ Million) Table 43. Global Glabridin Sales Value Share by Application (2021-2026) Table 44. Global Glabridin Sales Value Share by Application (2027-2032) Table 45. Global Glabridin Sales by Region: 2021 VS 2025 VS 2032 (Kg) Table 46. Global Glabridin Sales by Region (2021-2026) & (Kg) Table 47. Global Glabridin Sales Market Share by Region (2021-2026) Table 48. Global Glabridin Sales by Region (2027-2032) & (Kg) Table 49. Global Glabridin Sales Market Share by Region (2027-2032) Table 50. Global Glabridin Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Glabridin Sales Value by Region (2021-2026) & (US$ Million) Table 52. Global Glabridin Sales Value Share by Region (2021-2026) Table 53. Global Glabridin Sales Value by Region (2027-2032) & (US$ Million) Table 54. Global Glabridin Sales Value Share by Region (2027-2032) Table 55. Global Glabridin Market Average Price (US$/Kg) by Region (2021-2026) Table 56. Global Glabridin Market Average Price (US$/Kg) by Region (2027-2032) Table 57. Global Glabridin Sales by Country: 2021 VS 2025 VS 2032 (Kg) Table 58. Global Glabridin Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Glabridin Sales by Country (2021-2026) & (Kg) Table 60. Global Glabridin Sales Market Share by Country (2021-2026) Table 61. Global Glabridin Sales by Country (2027-2032) & (Kg) Table 62. Global Glabridin Sales Market Share by Country (2027-2032) Table 63. Global Glabridin Sales Value by Country (2021-2026) & (US$ Million) Table 64. Global Glabridin Sales Value Market Share by Country (2021-2026) Table 65. Global Glabridin Sales Value by Country (2027-2032) & (US$ Million) Table 66. Global Glabridin Sales Value Market Share by Country (2027-2032) Table 67. Sabinsa Company Information Table 68. Sabinsa Business Overview Table 69. Sabinsa Glabridin Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 70. Sabinsa Glabridin Product Portfolio Table 71. Sabinsa Recent Development Table 72. Alchem International Company Information Table 73. Alchem International Business Overview Table 74. Alchem International Glabridin Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 75. Alchem International Glabridin Product Portfolio Table 76. Alchem International Recent Development Table 77. MAFCO Company Information Table 78. MAFCO Business Overview Table 79. MAFCO Glabridin Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 80. MAFCO Glabridin Product Portfolio Table 81. MAFCO Recent Development Table 82. Plamed Green Science Group Company Information Table 83. Plamed Green Science Group Business Overview Table 84. Plamed Green Science Group Glabridin Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 85. Plamed Green Science Group Glabridin Product Portfolio Table 86. Plamed Green Science Group Recent Development Table 87. Xi'an Zhongying Company Information Table 88. Xi'an Zhongying Business Overview Table 89. Xi'an Zhongying Glabridin Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 90. Xi'an Zhongying Glabridin Product Portfolio Table 91. Xi'an Zhongying Recent Development Table 92. Spring Autumn Biological Company Information Table 93. Spring Autumn Biological Business Overview Table 94. Spring Autumn Biological Glabridin Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 95. Spring Autumn Biological Glabridin Product Portfolio Table 96. Spring Autumn Biological Recent Development Table 97. Huaian Brothers Biotechnology Company Information Table 98. Huaian Brothers Biotechnology Business Overview Table 99. Huaian Brothers Biotechnology Glabridin Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 100. Huaian Brothers Biotechnology Glabridin Product Portfolio Table 101. Huaian Brothers Biotechnology Recent Development Table 102. Xi’an Tianye Biotech Company Information Table 103. Xi’an Tianye Biotech Business Overview Table 104. Xi’an Tianye Biotech Glabridin Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 105. Xi’an Tianye Biotech Glabridin Product Portfolio Table 106. Xi’an Tianye Biotech Recent Development Table 107. Maruzen Pharmaceuticals Company Information Table 108. Maruzen Pharmaceuticals Business Overview Table 109. Maruzen Pharmaceuticals Glabridin Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 110. Maruzen Pharmaceuticals Glabridin Product Portfolio Table 111. Maruzen Pharmaceuticals Recent Development Table 112. SK Bioland Company Information Table 113. SK Bioland Business Overview Table 114. SK Bioland Glabridin Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 115. SK Bioland Glabridin Product Portfolio Table 116. SK Bioland Recent Development Table 117. Sunpure Extracts Company Information Table 118. Sunpure Extracts Business Overview Table 119. Sunpure Extracts Glabridin Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 120. Sunpure Extracts Glabridin Product Portfolio Table 121. Sunpure Extracts Recent Development Table 122. Key Raw Materials Table 123. Raw Materials Key Suppliers Table 124. Glabridin Distributors List Table 125. Glabridin Customers List Table 126. Research Programs/Design for This Report Table 127. Authors List of This Report Table 128. Secondary Sources Table 129. Primary Sources List of Figures Figure 1. Glabridin Product Image Figure 2. Global Glabridin Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Glabridin Sales Value (2021-2032) & (US$ Million) Figure 4. Global Glabridin Sales (2021-2032) & (Kg) Figure 5. Global Glabridin Sales Average Price (US$/Kg) & (2021-2032) Figure 6. Global Glabridin Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 20% (HPLC) Image Figure 10. 40% (HPLC) Image Figure 11. 60% (HPLC) Image Figure 12. 90% (HPLC) Image Figure 13. 98% (HPLC) Image Figure 14. Other Image Figure 15. Global Glabridin Sales Volume by Type (2021 VS 2025 VS 2032) & (Kg) Figure 16. Global Glabridin Sales Volume Share 2021 VS 2025 VS 2032 Figure 17. Global Glabridin Sales Volume Share by Type (2021-2032) Figure 18. Global Glabridin Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Glabridin Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global Glabridin Sales Value Share by Type (2021-2032) Figure 21. Cosmetic Image Figure 22. Pharmaceutical Image Figure 23. Global Glabridin Sales Volume by Application (2021 VS 2025 VS 2032) & (Kg) Figure 24. Global Glabridin Sales Volume Share 2021 VS 2025 VS 2032 Figure 25. Global Glabridin Sales Volume Share by Application (2021-2032) Figure 26. Global Glabridin Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Glabridin Sales Value Share 2021 VS 2025 VS 2032 Figure 28. Global Glabridin Sales Value Share by Application (2021-2032) Figure 29. Global Glabridin Sales by Region: 2021 VS 2025 VS 2032 (Kg) Figure 30. Global Glabridin Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 31. Global Glabridin Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 32. Global Glabridin Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 33. North America Glabridin Sales Value (2021-2032) & (US$ Million) Figure 34. North America Glabridin Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Europe Glabridin Sales Value (2021-2032) & (US$ Million) Figure 36. Europe Glabridin Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Asia-Pacific Glabridin Sales Value (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Glabridin Sales Value Share by Country (%), 2025 VS 2032 Figure 39. South America Glabridin Sales Value (2021-2032) & (US$ Million) Figure 40. South America Glabridin Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Middle East & Africa Glabridin Sales Value (2021-2032) & (US$ Million) Figure 42. Middle East & Africa Glabridin Sales Value Share by Country (%), 2025 VS 2032 Figure 43. USA Glabridin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. USA Glabridin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. USA Glabridin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Canada Glabridin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Canada Glabridin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Canada Glabridin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Mexico Glabridin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Mexico Glabridin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Mexico Glabridin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Germany Glabridin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Germany Glabridin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Germany Glabridin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. France Glabridin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. France Glabridin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. France Glabridin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. U.K. Glabridin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. U.K. Glabridin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. U.K. Glabridin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Italy Glabridin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Italy Glabridin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Italy Glabridin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Spain Glabridin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Spain Glabridin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Spain Glabridin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Russia Glabridin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Russia Glabridin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Russia Glabridin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Netherlands Glabridin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Netherlands Glabridin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Netherlands Glabridin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Nordic Countries Glabridin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Nordic Countries Glabridin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Nordic Countries Glabridin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. China Glabridin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. China Glabridin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. China Glabridin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Japan Glabridin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Japan Glabridin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Japan Glabridin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. South Korea Glabridin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. South Korea Glabridin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. South Korea Glabridin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. India Glabridin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. India Glabridin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. India Glabridin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Australia Glabridin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Australia Glabridin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Australia Glabridin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Southeast Asia Glabridin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Southeast Asia Glabridin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Southeast Asia Glabridin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Brazil Glabridin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Brazil Glabridin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Brazil Glabridin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Argentina Glabridin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Argentina Glabridin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Argentina Glabridin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Chile Glabridin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Chile Glabridin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Chile Glabridin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Colombia Glabridin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Colombia Glabridin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Colombia Glabridin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Peru Glabridin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Peru Glabridin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Peru Glabridin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Glabridin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Saudi Arabia Glabridin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Glabridin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Israel Glabridin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Israel Arabia Glabridin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Israel Arabia Glabridin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. UAE Glabridin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. UAE Glabridin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. UAE Glabridin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Turkey Glabridin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Turkey Glabridin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Turkey Glabridin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Iran Glabridin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Iran Glabridin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Iran Glabridin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Egypt Glabridin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Egypt Glabridin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Egypt Glabridin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Glabridin Value Chain Figure 128. Manufacturing Cost Structure Figure 129. Glabridin Sales Mode & Process Figure 130. Direct Comparison with Distribution Share Figure 131. Distributors Profiles Figure 132. Years Considered Figure 133. Research Process Figure 134. Key Executives Interviewed

Scope & coverage.

Types
  • 20% (HPLC)
  • 40% (HPLC)
  • 60% (HPLC)
  • 90% (HPLC)
  • 98% (HPLC)
  • Other
Applications
  • Cosmetic
  • Pharmaceutical
Companies covered
  • Sabinsa
  • Alchem International
  • MAFCO
  • Plamed Green Science Group
  • Xi'an Zhongying
  • Spring Autumn Biological
  • Huaian Brothers Biotechnology
  • Xi’an Tianye Biotech
  • Maruzen Pharmaceuticals
  • SK Bioland
  • Sunpure Extracts

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Glabridin Sales Value (2021-2032)
  4. 1.2.2 Global Glabridin Sales Volume (2021-2032)
  5. 1.2.3 Global Glabridin Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Glabridin Market Dynamics
  1. 2.1 Glabridin Industry Trends
  2. 2.2 Glabridin Industry Drivers
  3. 2.3 Glabridin Industry Opportunities and Challenges
  4. 2.4 Glabridin Industry Restraints
3 Glabridin Market by Company
  1. 3.1 Global Glabridin Company Revenue Ranking in 2025
  2. 3.2 Global Glabridin Revenue by Company (2021-2026)
  3. 3.3 Global Glabridin Sales Volume by Company (2021-2026)
  4. 3.4 Global Glabridin Average Price by Company (2021-2026)
  5. 3.5 Global Glabridin Company Ranking (2024-2026)
  6. 3.6 Global Glabridin Company Manufacturing Base and Headquarters
  7. 3.7 Global Glabridin Company Product Type and Application
  8. 3.8 Global Glabridin Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Glabridin Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Glabridin Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Glabridin Market by Type
  1. 4.1 Glabridin Type Introduction
  2. 4.1.1 20% (HPLC)
  3. 4.1.2 40% (HPLC)
  4. 4.1.3 60% (HPLC)
  5. 4.1.4 90% (HPLC)
  6. 4.1.5 98% (HPLC)
  7. 4.1.6 Other
  8. 4.2 Global Glabridin Sales Volume by Type
  9. 4.2.1 Global Glabridin Sales Volume by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Glabridin Sales Volume by Type (2021-2032)
  11. 4.2.3 Global Glabridin Sales Volume Share by Type (2021-2032)
  12. 4.3 Global Glabridin Sales Value by Type
  13. 4.3.1 Global Glabridin Sales Value by Type (2021 VS 2025 VS 2032)
  14. 4.3.2 Global Glabridin Sales Value by Type (2021-2032)
  15. 4.3.3 Global Glabridin Sales Value Share by Type (2021-2032)
5 Glabridin Market by Application
  1. 5.1 Glabridin Application Introduction
  2. 5.1.1 Cosmetic
  3. 5.1.2 Pharmaceutical
  4. 5.2 Global Glabridin Sales Volume by Application
  5. 5.2.1 Global Glabridin Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Glabridin Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Glabridin Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Glabridin Sales Value by Application
  9. 5.3.1 Global Glabridin Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Glabridin Sales Value by Application (2021-2032)
  11. 5.3.3 Global Glabridin Sales Value Share by Application (2021-2032)
6 Glabridin Regional Sales and Value Analysis
  1. 6.1 Global Glabridin Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Glabridin Sales by Region (2021-2032)
  3. 6.2.1 Global Glabridin Sales by Region: 2021-2026
  4. 6.2.2 Global Glabridin Sales by Region (2027-2032)
  5. 6.3 Global Glabridin Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Glabridin Sales Value by Region (2021-2032)
  7. 6.4.1 Global Glabridin Sales Value by Region: 2021-2026
  8. 6.4.2 Global Glabridin Sales Value by Region (2027-2032)
  9. 6.5 Global Glabridin Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Glabridin Sales Value (2021-2032)
  12. 6.6.2 North America Glabridin Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Glabridin Sales Value (2021-2032)
  15. 6.7.2 Europe Glabridin Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Glabridin Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Glabridin Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Glabridin Sales Value (2021-2032)
  21. 6.9.2 South America Glabridin Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Glabridin Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Glabridin Sales Value Share by Country, 2025 VS 2032
7 Glabridin Country-level Sales and Value Analysis
  1. 7.1 Global Glabridin Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Glabridin Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Glabridin Sales by Country (2021-2032)
  4. 7.3.1 Global Glabridin Sales by Country (2021-2026)
  5. 7.3.2 Global Glabridin Sales by Country (2027-2032)
  6. 7.4 Global Glabridin Sales Value by Country (2021-2032)
  7. 7.4.1 Global Glabridin Sales Value by Country (2021-2026)
  8. 7.4.2 Global Glabridin Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Glabridin Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Glabridin Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Glabridin Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Glabridin Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Glabridin Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Glabridin Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Glabridin Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Glabridin Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Glabridin Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Glabridin Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Glabridin Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Glabridin Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Glabridin Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Glabridin Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Glabridin Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Glabridin Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Glabridin Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Glabridin Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Glabridin Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Glabridin Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Glabridin Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Glabridin Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Glabridin Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Glabridin Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Glabridin Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Glabridin Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Glabridin Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Glabridin Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Glabridin Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Glabridin Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Glabridin Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Glabridin Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Glabridin Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Glabridin Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Glabridin Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Glabridin Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Glabridin Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Glabridin Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Glabridin Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Glabridin Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Glabridin Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Glabridin Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Glabridin Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Glabridin Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Glabridin Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Glabridin Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Glabridin Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Glabridin Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Glabridin Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Glabridin Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Glabridin Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Glabridin Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Glabridin Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Glabridin Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Glabridin Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Glabridin Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Glabridin Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Glabridin Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Glabridin Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Glabridin Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Glabridin Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Glabridin Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Glabridin Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Glabridin Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Glabridin Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Glabridin Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Glabridin Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Glabridin Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Glabridin Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Glabridin Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Glabridin Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Glabridin Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Glabridin Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Glabridin Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Glabridin Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Glabridin Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Glabridin Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Glabridin Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Glabridin Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Glabridin Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Glabridin Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Glabridin Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Glabridin Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Glabridin Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Sabinsa
  2. 8.1.1 Sabinsa Company Information
  3. 8.1.2 Sabinsa Business Overview
  4. 8.1.3 Sabinsa Glabridin Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Sabinsa Glabridin Product Portfolio
  6. 8.1.5 Sabinsa Recent Developments
  7. 8.2 Alchem International
  8. 8.2.1 Alchem International Company Information
  9. 8.2.2 Alchem International Business Overview
  10. 8.2.3 Alchem International Glabridin Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Alchem International Glabridin Product Portfolio
  12. 8.2.5 Alchem International Recent Developments
  13. 8.3 MAFCO
  14. 8.3.1 MAFCO Company Information
  15. 8.3.2 MAFCO Business Overview
  16. 8.3.3 MAFCO Glabridin Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 MAFCO Glabridin Product Portfolio
  18. 8.3.5 MAFCO Recent Developments
  19. 8.4 Plamed Green Science Group
  20. 8.4.1 Plamed Green Science Group Company Information
  21. 8.4.2 Plamed Green Science Group Business Overview
  22. 8.4.3 Plamed Green Science Group Glabridin Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Plamed Green Science Group Glabridin Product Portfolio
  24. 8.4.5 Plamed Green Science Group Recent Developments
  25. 8.5 Xi'an Zhongying
  26. 8.5.1 Xi'an Zhongying Company Information
  27. 8.5.2 Xi'an Zhongying Business Overview
  28. 8.5.3 Xi'an Zhongying Glabridin Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Xi'an Zhongying Glabridin Product Portfolio
  30. 8.5.5 Xi'an Zhongying Recent Developments
  31. 8.6 Spring Autumn Biological
  32. 8.6.1 Spring Autumn Biological Company Information
  33. 8.6.2 Spring Autumn Biological Business Overview
  34. 8.6.3 Spring Autumn Biological Glabridin Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Spring Autumn Biological Glabridin Product Portfolio
  36. 8.6.5 Spring Autumn Biological Recent Developments
  37. 8.7 Huaian Brothers Biotechnology
  38. 8.7.1 Huaian Brothers Biotechnology Company Information
  39. 8.7.2 Huaian Brothers Biotechnology Business Overview
  40. 8.7.3 Huaian Brothers Biotechnology Glabridin Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Huaian Brothers Biotechnology Glabridin Product Portfolio
  42. 8.7.5 Huaian Brothers Biotechnology Recent Developments
  43. 8.8 Xi’an Tianye Biotech
  44. 8.8.1 Xi’an Tianye Biotech Company Information
  45. 8.8.2 Xi’an Tianye Biotech Business Overview
  46. 8.8.3 Xi’an Tianye Biotech Glabridin Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Xi’an Tianye Biotech Glabridin Product Portfolio
  48. 8.8.5 Xi’an Tianye Biotech Recent Developments
  49. 8.9 Maruzen Pharmaceuticals
  50. 8.9.1 Maruzen Pharmaceuticals Company Information
  51. 8.9.2 Maruzen Pharmaceuticals Business Overview
  52. 8.9.3 Maruzen Pharmaceuticals Glabridin Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Maruzen Pharmaceuticals Glabridin Product Portfolio
  54. 8.9.5 Maruzen Pharmaceuticals Recent Developments
  55. 8.10 SK Bioland
  56. 8.10.1 SK Bioland Company Information
  57. 8.10.2 SK Bioland Business Overview
  58. 8.10.3 SK Bioland Glabridin Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 SK Bioland Glabridin Product Portfolio
  60. 8.10.5 SK Bioland Recent Developments
  61. 8.11 Sunpure Extracts
  62. 8.11.1 Sunpure Extracts Company Information
  63. 8.11.2 Sunpure Extracts Business Overview
  64. 8.11.3 Sunpure Extracts Glabridin Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Sunpure Extracts Glabridin Product Portfolio
  66. 8.11.5 Sunpure Extracts Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Glabridin Value Chain Analysis
  2. 9.1.1 Glabridin Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Glabridin Sales Mode & Process
  6. 9.2 Glabridin Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Glabridin Distributors
  9. 9.2.3 Glabridin Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst